NewsRoom Articles - Page 689 of 1389

ThursdayOct 31, 2019 10:58 am

Blockchain Pioneers Converge as World Crypto Con Kicks off in Las Vegas

Crypto industry leaders from across the globe converged at The Cosmopolitan of Las Vegas Wednesday for Day 1 of World Crypto Conference (“WCC”), which is part of the annual lineup of Vegas Blockchain Week events sponsored by EVOLV Events. This premier gathering of thought leaders, innovators, executives, enthusiasts, service providers, government policy advisors, developers and others in the space stands out as one of the foremost global stages for sharing breaking blockchain news and the latest cutting-edge technologies. From training and discussions to product demos and keynote addresses given by experts, the agenda for WCC Day 1 was jampacked. Attendees…

WednesdayOct 30, 2019 3:51 pm

Wild West Crypto Show Shines Spotlight on Blockchain Solutions for Business

It was another week at the speed of crypto, as episode 81 of The Wild West Crypto Show got underway. Broadcast from Kerrville, Texas, the weekly review of all things crypto is designed to entertain and educate, as well as keep viewers abreast of the latest developments in the space. The first guest on the show was Horizen Labs CEO Robert Viglione, who tuned in from Italy. Viglione wants to flip the old Silicon Valley business model – giving consumers a free product then taking all their data – upside down. He’s building a system that allows consumers to get…

WednesdayOct 30, 2019 3:33 pm

Petroteq Energy Inc.’s (TSX.V: PQE) (OTC: PQEFF) Closes Equity Financing, Invests Proceeds in Its Innovative Extraction Technology

First announced in September 2019, the equity financing generated proceeds of $500,000 The financing is part of an ongoing effort to secure the capital required to enhance the company’s Asphalt Ridge oil extraction processes Extraction operations were recently resumed at Asphalt Ridge after facility upgrades Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) announced on October 18, 2019, the final closing of equity financing initiated one month prior. According to a news release, the company generated gross proceeds of $500,000 through the issuance of 2,777,777 units sold at $0.18 each (http://nnw.fm/8XlSF). Funds generated through the equity financing will be put towards…

WednesdayOct 30, 2019 3:17 pm

No End to Broadening Neutra Corp. (NTRR) Horizons in Sight: Company Targets New Hemp-Based CBD Products and Markets

New LOI would allow the company to join development of a wide range of hemp-based medicinal products Neutra would also gain access to a cultivation license and a research license to examine the role of cannabinoids as antioxidants and neuro-protectants CBD sales in the U.S. expected to exceed $20 billion by 2024; hemp-based CBD product sales reached $390 in 2018 and are expected to more than triple over the next couple of years Early-stage research and development company Neutra Corp. (OTC: NTRR) executed a Letter of Intent (LOI) that could lead to the joint development of a vast selection of…

WednesdayOct 30, 2019 12:25 pm

HTC Extraction Systems (TSX.V: HTC) to Expand Operations with $10 Million in New Funding

HTC recently closed a bought deal private placement worth $10 million in funding Demand for hemp biomass continues to grow with the U.S. hemp-derived CBD market expected to reach $22 billion by 2022 HTC’s proprietary biomass processing methodology maximizes extraction and purification of hemp biomass After successfully raising $10 million in a private placement financing of 25 million units of the company, HTC Extraction Systems (TSX.V: HTC) is poised to expand its role in the cannabidiol (CBD) extraction market. HTC plans to use the funds for purchase of extraction, purification and refining equipment, and for general working capital purposes, the company…

WednesdayOct 30, 2019 11:51 am

Predictive Oncology Inc.’s (NASDAQ: POAI) Valuable Database Offers Hope to Cancer Patients of Today and Tomorrow

Predictive Oncology Inc. harnessing the power of artificial intelligence and its rich database of tumor data to help clinicians match cancer patients with most effective drug treatments Like Amazon’s customer dataset, POAI’s deep database of historical tumor information positions it for industry success Precision medicine is a data problem – demonstrates the huge value of data and those companies that generate it When shopping on Amazon, it seems like the multinational technology company knows its customers intimately. Every product filtered into a search query response seems carefully curated to match each customer. This ability to leverage big data has pushed…

WednesdayOct 30, 2019 11:18 am

VPR Brands LP (VPRB) Among Industry Players Awaiting Final USDA Hemp Rules

VPRB among key players anticipating United States Department of Agriculture (USDA) final draft rules on industrial hemp USDA’s Deputy Secretary Stephen Censky noted the regulations’ release to be expected within weeks, ahead of 2020 planting season Interim rules drafted include input from myriad voices; intend to relieve burden on producers, stakeholders VPR Brands LP (OTCQB: VPRB), a multi-vertical tiered technology holding company in the cannabis space including vaping, joins other hemp industry players in their anticipation of the United States Department of Agriculture’s (USDA) release of an interim final rule for its Hemp Program. This announcement is timed in advance…

TuesdayOct 29, 2019 4:30 pm

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Starts Presentation at Dawson James Small Cap Growth Conference

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is a specialty pharmaceutical company focused on anti-infectives, cancer care and unique prescription products that use innovative, patented or proprietary formulations of previously approved pharmaceutical ingredients. By using previously approved drugs with substantial safety and efficacy data, the company seeks to reduce risks associated with pharmaceutical product development and regulatory requirements. The company develops products that have intellectual property protection and competitive advantages to existing therapeutic approaches. Citius intends to achieve leading market positions by providing therapeutic products that address unmet medical needs. For more information, visit the company's website at www.citiuspharma.com. About NetworkNewsWire NetworkNewsWire (NNW)…

TuesdayOct 29, 2019 4:30 pm

BioCardia (NASDAQ: BCDA) Starts Presentation at Dawson James Small Cap Growth Conference

BioCardia (NASDAQ: BCDA) is developing regenerative biologic therapies to treat cardiovascular disease. CardiAMP™ and CardiALLO™ cell therapies are the company's biotherapeutic product candidates in clinical development. BioCardia's current products include the Helix™ Biotherapeutic Delivery System and the Morph® steerable guide and sheath catheter portfolio, including the new AVANCE™ Steerable Introducer family. BioCardia also partners with other biotherapeutic companies to provide its Helix systems and clinical support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia and acute myocardial infarction. For more information, visit the company's website at www.biocardia.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news…

TuesdayOct 29, 2019 4:05 pm

DelMar Pharmaceuticals Inc. (NASDAQ: DMPI) Starts Presentation at Dawson James Small Cap Growth Conference

DelMar Pharmaceuticals (NASDAQ: DMPI) concentrates on the development and commercialization of new therapies for cancer patients who have limited or no treatment options. Focused on understanding tumor biology and mechanisms of treatment resistance, DelMar identifies biomarkers to personalize new therapies in indications where patients are failing, or are unable to tolerate, standard-of-care treatments. The company's current pipeline is based around VAL-083, a "first-in-class", small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers including central nervous system, ovarian and other solid tumors in U.S. clinical trials sponsored by the NCI. Delmar is…

Financial news and publishing for public and private companies

Contact us: 512.354.7000